SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019478
Filing Date
2021-08-11
Accepted
2021-08-11 16:31:36
Documents
48
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20210630_10q.htm   iXBRL 10-Q 608808
2 EXHIBIT 31.1 ex_271972.htm EX-31.1 13318
3 EXHIBIT 31.2 ex_271973.htm EX-31.2 13297
4 EXHIBIT 32.1 ex_271974.htm EX-32.1 5443
5 EXHIBIT 32.2 ex_271975.htm EX-32.2 5433
  Complete submission text file 0001437749-21-019478.txt   2693295

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20210630.xsd EX-101.SCH 28447
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20210630_cal.xml EX-101.CAL 26040
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20210630_def.xml EX-101.DEF 204245
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20210630_lab.xml EX-101.LAB 180730
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20210630_pre.xml EX-101.PRE 220368
11 EXTRACTED XBRL INSTANCE DOCUMENT govx20210630_10q_htm.xml XML 211531
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 211163874
SIC: 2834 Pharmaceutical Preparations